Completed Bones, Joints & Muscles Genetics & Molecular Biology

Defining disease mechanisms in mouse models of chondrodysplasia.

In plain English

AI plain-English summary

Some children are born with severely shortened limbs because their growth plates fail to build bone properly. This fellowship aims to understand exactly why that happens. The researcher has already created mouse models of two human skeletal disorders—PSACH and MED—caused by mutations in the COMP and matrilin-3 genes. In these mice, bone growth stalls because cartilage cells (chondrocytes) stop dividing and die in the wrong places, likely due to cellular stress from the mutant proteins. Now the work will untangle three key questions: whether the unfolded protein response and cell stress drive growth plate failure, whether changes in the cartilage’s structural scaffold contribute, and how much of the damage comes from inside cells versus outside them. This is fundamental science. It will not produce a treatment tomorrow. But by pinpointing the chain of events from a single gene mutation to a misshapen skeleton, the findings could illuminate disease mechanisms not only in PSACH and MED but across a wide range of inherited connective tissue disorders. Understanding how a cell’s stress response derails bone growth may eventually point to molecular targets for therapy—much as basic discoveries about protein folding in yeast opened the door to treatments for cystic fibrosis and Alzheimer’s disease.

View original technical description
The aim of this Fellowship is to determine the mechanisms of long bone growth and to characterise disease processes in human skeletal dysplasia. To determine the mechanistic link between the expression of a mutant gene and the resulting disruption to long-bone growth I generated mouse models of PSACH-MED resulting from mutations in COMP and matrilin-3. I have shown that reduced bone growth in these models results from decreased chondrocyte proliferation and increased/spatially dysregulated apopt osis. This change in cell phenotype is most likely due to cell stress induced by the expression of the mutant gene products. I will now use a multidisciplinary approach to determine 1) the contribution of UPR and cell stress to growth plate dysplasia and reduced bone growth, 2) if changes in the structure and function of the cartilage ECM contribute to the disease process and 3) the relative contributions of intracellular and extracellular disease mechanisms to the overall pathophysiology of cho ndrodysplasia. These studies will provide essential insight in the pathology of PSACH-MED and suggest potential therapies. They will also have a major impact on our understanding of disease mechanisms in other forms of chondrodysplasia and a broad spectrum of inherited connective tissue diseases.

View the original record at the funder ↗

Researchers

Michael Briggs (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Understanding skeletal diseases using human induced pluripotent stem cells
Investigating CHD3-associated craniofacial syndromes
Studying the consequences of chromatin disruption in Cornelia de Lange Syndrome
A human model for the rare condition Acrodysostosis type2
Enhancing Chondrogenesis via modulation of Sirt1 activity for cartilage repair

Original classification

Senior Research Fellowship Basic Renewal

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.